3Leeman MF,McKay JA,Murray GI.Matrix metalloproteinase13activity is associated with poor prognosis in colorectal cancer.Clin Pathol,2002,55(10):758-762.
4Lee JH,Miele ME,Hicks DJ,et al.KISS-1,a novel human ma-lignant melanoma metastasis suppressor gene.J Natl Cancer Inst,1996,88(23):1731-1737.
5Stafford LJ,Xia C,Ma W,et al.Identification and characteriza-tion of mouse metastasis suppressor KiSS-1and its G-protein-coupled receptor.Cancer Res,2002,62(19):5399.
6Kazuyuki N,Ryuichiro D,Tatsuo I,et al.Prognostic value of metastin expression in human pancreatic cancer.J Exp Clin Cancer Res,2009,28:9.
7Lee JH,Welch DR.Suppression of metastasis in human breast carcinoma MDA-MB2435cells after transfection with the metas-tasis suppressor gene,KISS-1.Cancer Res,1997,57(12):2384-2387.
8Ringel MD,Hardy E,Bernet VJ,et al.Metastin receptor is over-expressed in papillary thyroid cancer and activates MAP kinasein thyroid cancer cells.J Clin Endocrinol Metab,2002,87(5):2399.
9Wang PH,Ko JL,Tsai HT,et al.Clinical significance of matrix metalloproteinase-2in cancer of uterine cervix:a semiquantitative study of immunocreactivities using tissue array.Gynecol Oncol,2008,108(3):533-542.
10Pantel K,Brakenhoff RH.Dissecting the metastatic cascade.Nat Rev Cancer,2004,4(6):448-456.
3Xing J C,Tufano R P, Murugan A K, et al. Single nucleotide polymorphism rs17849071G/T in the PIK3CA gene is inversely associated with follicular thyroid cancer and PIK3CA amplification. PLoS One,2012,7(11).
4Hirsch E Lembo G, Montrucchio G, et al. Signaling through Pi3Kgamma: a common platform for leukocyte, platelet and cardiovascular stress sensing. Thromb Haemost, 2006, 95 ( 1 ) :29- 35.
5Cantley L C. The phosphoinositide 3-kinase pathway. Science, 2002,296 ( 5573 ) : 1655-1657.
6Teicher B A, Fficker P. CXCLI2 ( SDF-I )/CXCR4 pathway in cancer. Clin Cancer Res,2010,16( 11 ) :2927-2931.
7Kwon K H,Lee Y C, Chung J H, et al. Association study of chemokine (C-C motif) ligand 5 gene polymorphism and papillal.'y thyroid cancer. J lnvest Surg,2013,26 ( 6 ) : 319- 324.
8Weng C J,Chien M H, Lin C W, et al. Effect of CC chemokine ligand 5 and CC chemokine receptor 5 genes polymorphisms on the risk and clinicopathological development of oral cancer. Oral Oncol, 2010,46:767-772.
9Azenshtein E,Luboshits G, Shina S, et al. The CC chemnkine RANTES in breast carcinoma progression: regulation of expression and potential mechanisms of promalignant activity. Cancer Res, 2002,62 : 1093-1102.
10Ambrosini G,Adida C, Ahieri D C. A novel anti-apoptosis gent, survivin, expressed in cancer and lymphoma. Nat Med, 1997,3 (8) :917-921.
